Hospitals have been loudly protesting recent changes to an obscure Medicare program known as 340B drug discount program, saying that these changes put patient care at risk. The truth is, hospitals are most concerned with protecting their profit margins.

Patient Struggles With 340B Are Being Addressed

Dr Nathaniel Wisch Honored in Ceremony

New York Cancer & Blood Specialists is very happy to announce our current Employee of the Month: Georganne “Gigi” Mazzuchelli! Gigi is a valued member of our team, serving as an LPN with us for over seven years. Gigi is an outstanding LPN who is both kind and compassionate to everyone she meets. Patients and co-workers describe her as being meticulous in her position, while also being extremely caring. Her disposition, demeanor, and wonderful personality have an amazing way of putting patients at ease. Gigi has always been described as a pleasure to work with and a valuable member of the healthcare team! Congratulations Gigi, very well-deserved!

Dr. Harry Staszewski Press Release

Dr. Harry Staszewski joins New York Cancer & Blood Specialists! See the above article!

Our CEO, Dr. Jeffrey Vacirca, penned this fascinating and eye-opening article on our Nation’s Cancer Care System.

Expansion and Innovation at New York Cancer & Blood Specialists

22-Year-Old Colon Cancer Survivor, from Hampton Bays, Shares Personal Battle on Dr. Oz Show

Payment reform, ‘runaway growth’ of 340B top new Community Oncology Alliance president’s priorities